Our call on Nufarm pays off...
/Whilst not without its challenges (which probably led to many investors cutting their losses and exiting the stock), NUF's recent share price re-rating is a good example of patient investing. We reiterated our positive view on the stock to our investors in March with a valuation of $6.70 (versus price at the time of $4.71). Since this last published note the stock is up +38.5%. NUF still has its challenges but recent company announcements highlight how good management teams find ways to navigate tough time. Not out of the woods but better placed.